Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Medical Simulation Market by Product & Service (Model-based Simulation, Web-based simulation, and Simulation Training Services), Fidelity (Low-fidelity, Medium-fidelity, and High-Fidelity), and End User (Academic Institutes and Research Centers, Hospitals & Clinics, and Military Organizations) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_182598

Pages: 195

Formats:

Feb 2018 | 3265 Views

Charts: 37

Tables: 105

Author(s): Prateeksha Kaul and Pallavi Jaiswal

Purchase Option


Medical Simulation Market Overview:

The Global Medical Simulation Market was valued at $986 million in 2016, and is estimated to reach $2,526 million by 2023, registering a CAGR of 14.3% from 2017 to 2023. Medical simulation is a process of simulating a real-life medical situation to demonstrate and train healthcare professionals. The global medical simulation market is driven by factors such as growing emphasis on patient safety & outcomes, associated benefits of medical simulation such as illustrating complex and normal cases to professionals, and enlightening the medical fraternity about the evolution of medical technology. However, high set-up cost of simulation and other related costs are expected to impede the market growth.

 Get more information on this report : Request Sample Pages

Surge in Mortality Rate Due to Medical Errors

According to an article published by NCBI, more than 250,000 patients die every year due to medical errors, which makes it the third leading cause of death in the world. The advent of simulation in healthcare has significantly reduced the number of deaths due to unsafe care. Moreover, the performance of clinicians, especially improving patient safety outcomes, has improved in the recent years with the use of simulation techniques. These factors are expected to boost the growth of the market in the near future.

 Get more information on this report : Request Sample Pages

The global medical simulation market is segmented based on product & services, fidelity, end user, and region. Based on product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. Model-based simulation is further classified into patient simulation, surgical simulation, and ultrasound simulation. Patient simulation is segmented further into task trainers, manikin-based simulators, and standardized patient simulators. Surgical simulation is sub-segmented into laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. Web-based simulation segment is categorized into simulation software, performance recording software, and virtual tutors. Simulation training services consist of vendor-based training services, custom consulting services, and educational society services. Based on fidelity, the market is classified into low-fidelity, medium fidelity, and high-fidelity simulators. The end users of the industry are broadly divided into academic institutions & research centers, hospitals & clinics, and military organizations. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players profiled in the report are Laerdal Medical AS, CAE, Inc., 3D Systems, Inc., Simulab Corporation, Simulaids, Inc., Limbs and Things, Ltd., Kyoto Kagaku Co. Ltd., Mentice AB, Surgical Science Sweden AB, and Gaumard Scientific Company, Inc.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global medical simulation market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis of the market from 2016 to 2023 is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Medical Simulation Market Key Segments:

By Product & Service

  • Model-based Simulation
    • Patient Simulation
      • Task Trainer Simulation
      • Manikin-based Simulation
      • Standardized Patient Simulation
    • Surgical Simulation
      • Laparoscopic Surgical Simulators
      • Arthroscopic Surgical Simulators
      • Cardiovascular Simulators
      • Gynecology Simulators
      • Others
    • Ultrasound Simulation
  • Web-based Simulation
    • Simulation Software
    • Performance Recording Software
    • Virtual Tutors
  • Simulation Training Services
    • Vendor-based Training
    • Custom Consulting Services
    • Educational Societies

By Fidelity

  • Low-fidelity
  • Medium-fidelity
  • High-fidelity

By End User

  • Academic Institutions & Research Centers
  • Hospitals & Clinics
  • Military Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    •  China
    •  India
    •  Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    •  Saudi Arabia
    •  South Africa
    •  Rest of LAMEA

CHAPTER 1:    INTRODUCTION

1.1.    REPORT DESCRIPTION
1.2.    KEY BENEFITS FOR STAKEHOLDERS
1.3.    KEY MARKET SEGMENTS
1.4.    RESEARCH METHODOLOGY

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top winning strategies
3.2.2.    Top investment pockets

3.3.    Market share analysis, 2016
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Low expenditure on healthcare
3.4.1.2.    Assured improvement in patient safety outcomes
3.4.1.3.    Benefits of medical simulation
3.4.1.4.    Technological advancements in medical field

3.4.2.    Restraints

3.4.2.1.    High cost of setting up simulators
3.4.2.2.    Limitation of a complete real situation

3.4.3.    Opportunities

3.4.3.1.    Lucrative opportunities in emerging markets

3.4.4.    Impact analyses

CHAPTER 4:    MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Model based simulation

4.2.1.    Market size and forecast by type

4.2.1.1.    Patient simulation

4.2.1.1.1.    Market size and forecast

4.2.1.1.1.1.    Task trainer simulation: Market Size and Forecast
4.2.1.1.1.2.    Manikin-based simulation: Market Size and Forecast
4.2.1.1.1.3.    Standardized Patient Simulation: Market Size and Forecast

4.2.1.2.    Surgical simulation

4.2.1.2.1.    Market size and forecast

4.2.1.2.1.1.    Laparoscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.2.    Arthroscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.3.    Cardiovascular Simulators: Market Size and Forecast
4.2.1.2.1.4.    Gynecology Simulators: Market Size and Forecast
4.2.1.2.1.5.    Others: Market Size and Forecast

4.2.1.3.    Ultrasound simulation

4.2.1.3.1.    Market size and forecast

4.2.2.    Market size and forecast by region
4.2.3.    Market analysis, by country

4.3.    Web-based simulation

4.3.1.    Market size and forecast by type

4.3.1.1.    Simulation Software: Market Size and Forecast
4.3.1.2.    Performance Recording Software: Market Size and Forecast
4.3.1.3.    Virtual Tutors: Market Size and Forecast

4.3.2.    Market size and forecast by region
4.3.3.    Market analysis, by country

4.4.    Simulation Training Services

4.4.1.    Market size and forecast by type

4.4.1.1.    Vendor-based Training: Market Size and Forecast
4.4.1.2.    Custom Consulting Services: Market Size and Forecast
4.4.1.3.    Educational Societies: Market Size and Forecast

4.4.2.    Market size and forecast by region
4.4.3.    Market analysis, by country

CHAPTER 5:    MEDICAL SIMULATION MARKET, BY FIDELITY

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Low-fidelity

5.2.1.    Market size and forecast by region
5.2.2.    Market analysis, by country

5.3.    Medium-fidelity

5.3.1.    Market size and forecast by region
5.3.2.    Market analysis, by country

5.4.    High-fidelity

5.4.1.    Market size and forecast by region
5.4.2.    Market analysis, by country

CHAPTER 6:    MEDICAL SIMULATION MARKET, BY END USER

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Academic Institutions & Research Centers

6.2.1.    Market size and forecast by region
6.2.2.    Market analysis, by country

6.3.    Hospitals & Clinics

6.3.1.    Market size and forecast by region
6.3.2.    Market analysis, by country

6.4.    Military Organizations

6.4.1.    Market size and forecast by region
6.4.2.    Market analysis, by country

CHAPTER 7:    MEDICAL SIMULATION, BY REGION

7.1.    Market size and forecast
7.2.    North America

7.2.1.    North America: Market Size and Forecast, by country

7.2.1.1.    U.S. medical simulation: Market Size and Forecast

7.2.1.1.1.    U.S. medical simulation: market size and forecast by product & service
7.2.1.1.2.    U.S. medical simulation: market size and forecast by fidelity
7.2.1.1.3.    U.S. medical simulation: market size and forecast by end user

7.2.1.2.    Canada medical simulation: Market Size and Forecast

7.2.1.2.1.    Canada medical simulation: market size and forecast by product & service
7.2.1.2.2.    Canada medical simulation: market size and forecast by fidelity
7.2.1.2.3.    Canada medical simulation: market size and forecast by end user

7.2.1.3.    Mexico medical simulation: Market Size and Forecast

7.2.1.3.1.    Mexico medical simulation: market size and forecast by product & service
7.2.1.3.2.    Mexico medical simulation: market size and forecast by fidelity
7.2.1.3.3.    Mexico medical simulation: market size and forecast by end user

7.2.2.    North America: market size and forecast by product & service
7.2.3.    North America: market size and forecast by fidelity
7.2.4.    North America: market size and forecast by end user

7.3.    Europe

7.3.1.    Europe: Market Size and Forecast, by country

7.3.1.1.    Germany medical simulation: Market Size and Forecast

7.3.1.1.1.    Germany medical simulation: market size and forecast by product & service
7.3.1.1.2.    Germany medical simulation: market size and forecast by fidelity
7.3.1.1.3.    Germany medical simulation: market size and forecast by end user

7.3.1.2.    France medical simulation: Market Size and Forecast

7.3.1.2.1.    France medical simulation: market size and forecast by product & service
7.3.1.2.2.    France medical simulation: market size and forecast by fidelity
7.3.1.2.3.    France medical simulation: market size and forecast by end user

7.3.1.3.    UK medical simulation: Market Size and Forecast

7.3.1.3.1.    UK medical simulation: market size and forecast by product & service
7.3.1.3.2.    UK medical simulation: market size and forecast by fidelity
7.3.1.3.3.    UK medical simulation: market size and forecast by end user

7.3.1.4.    Italy medical simulation: Market Size and Forecast

7.3.1.4.1.    Italy medical simulation: market size and forecast by product & service
7.3.1.4.2.    Italy medical simulation: market size and forecast by fidelity
7.3.1.4.3.    Italy medical simulation: market size and forecast by end user

7.3.1.5.    Spain medical simulation: Market Size and Forecast

7.3.1.5.1.    Spain medical simulation: market size and forecast by product & service
7.3.1.5.2.    Spain medical simulation: market size and forecast by fidelity
7.3.1.5.3.    Spain medical simulation: market size and forecast by end user

7.3.1.6.    Austria medical simulation
7.3.1.7.    Market Size and Forecast

7.3.1.7.1.    Austria medical simulation: market size and forecast by product & service
7.3.1.7.2.    Austria medical simulation: market size and forecast by fidelity
7.3.1.7.3.    Austria medical simulation: market size and forecast by end user

7.3.1.8.    Poland medical simulation
7.3.1.9.    Market Size and Forecast

7.3.1.9.1.    Poland medical simulation: market size and forecast by product & service
7.3.1.9.2.    Poland medical simulation: market size and forecast by fidelity
7.3.1.9.3.    Poland medical simulation: market size and forecast by end user

7.3.1.10.    Czech medical simulation
7.3.1.11.    Market Size and Forecast

7.3.1.11.1.    Czech medical simulation: market size and forecast by product & service
7.3.1.11.2.    Czech medical simulation: market size and forecast by fidelity
7.3.1.11.3.    Czech medical simulation: market size and forecast by end user

7.3.1.12.    Slovakia medical simulation
7.3.1.13.    Market Size and Forecast

7.3.1.13.1.    Slovakia medical simulation: market size and forecast by product & service
7.3.1.13.2.    Slovakia medical simulation: market size and forecast by fidelity
7.3.1.13.3.    Slovakia medical simulation: market size and forecast by end user

7.3.1.14.    Hungary medical simulation
7.3.1.15.    Market Size and Forecast

7.3.1.15.1.    Hungary medical simulation: market size and forecast by product & service
7.3.1.15.2.    Hungary medical simulation: market size and forecast by fidelity
7.3.1.15.3.    Romania medical simulation: market size and forecast by end user

7.3.1.16.    Romania medical simulation
7.3.1.17.    Market Size and Forecast

7.3.1.17.1.    Romania medical simulation: market size and forecast by product & service
7.3.1.17.2.    Romania medical simulation: market size and forecast by fidelity
7.3.1.17.3.    Romania medical simulation: market size and forecast by end user

7.3.1.18.    Slovenia medical simulation
7.3.1.19.    Market Size and Forecast

7.3.1.19.1.    Slovenia medical simulation: market size and forecast by product & service
7.3.1.19.2.    Slovenia medical simulation: market size and forecast by fidelity
7.3.1.19.3.    Slovenia medical simulation: market size and forecast by end user

7.3.1.20.    Rest of Europe medical simulation: Market Size and Forecast

7.3.1.20.1.    Rest of Europe medical simulation: market size and forecast by product & service
7.3.1.20.2.    Rest of Europe medical simulation: market size and forecast by fidelity
7.3.1.20.3.    Rest of Europe medical simulation: market size and forecast by end user

7.3.1.21.    Europe: market size and forecast by product & service

7.3.2.    Europe: market size and forecast by fidelity
7.3.3.    Europe: market size and forecast by end user

7.4.    Asia-pacific

7.4.1.    Asia-pacific: Market Size and Forecast, by country

7.4.1.1.    Japan medical simulation: Market Size and Forecast

7.4.1.1.1.    Japan medical simulation: market size and forecast by product & service
7.4.1.1.2.    Japan medical simulation: market size and forecast by fidelity
7.4.1.1.3.    Japan medical simulation: market size and forecast by end user

7.4.1.2.    China medical simulation: Market Size and Forecast

7.4.1.2.1.    China medical simulation: market size and forecast by product & service
7.4.1.2.2.    China medical simulation: market size and forecast by fidelity
7.4.1.2.3.    China medical simulation: market size and forecast by end user

7.4.1.3.    India medical simulation: Market Size and Forecast

7.4.1.3.1.    India medical simulation: market size and forecast by product & service
7.4.1.3.2.    India medical simulation: market size and forecast by fidelity
7.4.1.3.3.    India medical simulation: market size and forecast by end user

7.4.1.4.    Australia medical simulation: Market Size and Forecast

7.4.1.4.1.    Australia medical simulation: market size and forecast by product & service
7.4.1.4.2.    Australia medical simulation: market size and forecast by fidelity
7.4.1.4.3.    Australia medical simulation: market size and forecast by end user

7.4.1.5.    Rest of Asia-pacific medical simulation: Market Size and Forecast

7.4.1.5.1.    Rest of Asia-pacific medical simulation: market size and forecast by product & service
7.4.1.5.2.    Rest of Asia-pacific medical simulation: market size and forecast by fidelity
7.4.1.5.3.    Rest of Asia-pacific medical simulation: market size and forecast by end user

7.4.2.    Asia-pacific: market size and forecast by product & service

7.4.3.    Asia-pacific: market size and forecast by fidelity
7.4.4.    Asia-pacific: market size and forecast by end user

7.5.    LAMEA

7.5.1.    LAMEA: Market Size and Forecast, by country

7.5.1.1.    Brazil medical simulation: Market Size and Forecast

7.5.1.1.1.    Brazil medical simulation: market size and forecast by product & service
7.5.1.1.2.    Brazil medical simulation: market size and forecast by fidelity
7.5.1.1.3.    Brazil medical simulation: market size and forecast by end user

7.5.1.2.    South Africa medical simulation: Market Size and Forecast

7.5.1.2.1.    South Africa medical simulation: market size and forecast by product & service
7.5.1.2.2.    South Africa medical simulation: market size and forecast by fidelity
7.5.1.2.3.    South Africa medical simulation: market size and forecast by end user

7.5.1.3.    Saudi Arabia medical simulation: Market Size and Forecast

7.5.1.3.1.    Saudi Arabia medical simulation: market size and forecast by product & service
7.5.1.3.2.    Saudi Arabia medical simulation: market size and forecast by fidelity
7.5.1.3.3.    Saudi Arabia medical simulation: market size and forecast by end user

7.5.1.4.    Rest of LAMEA medical simulation: Market Size and Forecast

7.5.1.4.1.    Rest of LAMEA medical simulation: market size and forecast by product & service
7.5.1.4.2.    Rest of LAMEA medical simulation: market size and forecast by fidelity
7.5.1.4.3.    Rest of LAMEA medical simulation: market size and forecast by end user

7.5.2.    LAMEA: market size and forecast by product & service
7.5.3.    LAMEA: market size and forecast by fidelity
7.5.4.    LAMEA: market size and forecast by end user

CHAPTER 8:    COMPANY PROFILES

8.1.    3D Systems Corporation (Simbionix)

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Business performance
8.1.4.    Key strategic moves and developments

8.2.    CAE Inc.

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Business performance
8.2.5.    Key strategic moves and developments

8.3.    Gaumard Scientific Company

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Key strategic moves and developments

8.4.    Kyoto Kagaku Co. Ltd.

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments

8.5.    Laerdal Medical AS

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Key strategic moves and developments

8.6.    Limbs and Things Ltd.

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Key strategic moves and developments

8.7.    Mentice AB

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Key strategic moves and developments

8.8.    Simulab Corporation

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments

8.9.    Simulaids Inc.

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Key strategic moves and developments

8.10.    Surgical Science Sweden AB

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Business performance
8.10.4.    Key strategic moves and developments

LIST OF TABLES

TABLE 01.    GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 02.    GLOBAL MODEL-BASED SIMULATION MARKET REVENUE, BY TYPE, 2016–2023 ($MILLION)
TABLE 03.    GLOBAL PATIENT SIMULATION MARKET REVENUE, BY TYPE, 2016–2023 ($MILLION)
TABLE 04.    GLOBAL SURGICAL SIMULATION MARKET REVENUE, BY TYPE, 2016–2023 ($MILLION)
TABLE 05.    GLOBAL MODEL-BASED SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 06.    GLOBAL WEB-BASED SIMULATION MARKET REVENUE, BY TYPE, 2016–2023 ($MILLION)
TABLE 07.    WEB-BASED SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 08.    GLOBAL SIMULATION TRAINING SERVICES MARKET REVENUE, BY TYPE, 2016–2023 ($MILLION)
TABLE 09.    SIMULATION TRAINING SERVICES MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 10.    GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 11.    LOW-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 12.    MEDIUM-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 13.    HIGH-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 14.    GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 15.    MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS & RESEARCH CENTERS, BY REGION, 2016–2023 ($MILLION)
TABLE 16.    MEDICAL SIMULATION MARKET FOR HOSPITALS & CLINICS MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 17.    MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 18.    MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2016–2023 ($MILLION)
TABLE 19.    NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 20.    U.S. MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 21.    U.S. MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 22.    U.S. MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 23.    CANADA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 24.    CANADA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 25.    CANADA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 26.    MEXICO MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 27.    MEXICO MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 28.    MEXICO MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 29.    NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 30.    NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 31.    NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 32.    EUROPE MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 33.    GERMANY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 34.    GERMANY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 35.    GERMANY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 36.    FRANCE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 37.    FRANCE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 38.    FRANCE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 39.    UK MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 40.    UK MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 41.    UK MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 42.    ITALY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 43.    ITALY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 44.    ITALY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 45.    SPAIN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 46.    SPAIN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 47.    SPAIN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 48.    AUSTRIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 49.    AUSTRIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 50.    AUSTRIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 51.    POLAND MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 52.    POLAND MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 53.    POLAND MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 54.    CZECH MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 55.    CZECH MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 56.    CZECH MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 57.    SLOVAKIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 58.    SLOVAKIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 59.    SLOVAKIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 60.    HUNGARY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 61.    HUNGARY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 62.    ROMANIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 63.    ROMANIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 64.    ROMANIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 65.    ROMANIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 66.    SLOVENIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 67.    SLOVENIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 68.    SLOVENIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 69.    REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 70.    REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 71.    REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 72.    EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 73.    EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 74.    EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 75.    ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 76.    JAPAN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 77.    JAPAN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 78.    JAPAN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 79.    CHINA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 80.    CHINA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 81.    CHINA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 82.    INDIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 83.    INDIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 84.    INDIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 85.    AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 86.    AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 87.    AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 88.    REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 89.    REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 90.    REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 91.    ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 92.    ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 93.    ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 94.    LAMEA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 95.    BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 96.    BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 97.    BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 98.    SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 99.    SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 100.    SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 101.    SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 102.    SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 103.    SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 104.    REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 105.    REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 106.    REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 107.    LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2016–2023 ($MILLION)
TABLE 108.    LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2016–2023 ($MILLION)
TABLE 109.    LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2016–2023 ($MILLION)
TABLE 110.    3D SYSTEMS: COMPANY SNAPSHOT
TABLE 111.    CAE: COMPANY SNAPSHOT
TABLE 112.    CAE: OPERATING SEGMENTS
TABLE 113.    GAUMARD: COMPANY SNAPSHOT
TABLE 114.    KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 115.    KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 116.    LAERDAL: COMPANY SNAPSHOT
TABLE 117.    LAERDAL: OPERATING SEGMENTS
TABLE 118.    LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 119.    LIMBS & THINGS: OPERATING SEGMENTS
TABLE 120.    MENTICE: COMPANY SNAPSHOT
TABLE 121.    MENTICE: OPERATING SEGMENTS
TABLE 122.    SIMULAB: COMPANY SNAPSHOT
TABLE 123.    SIMULAB: OPERATING SEGMENTS
TABLE 124.    SIMULAIDS: COMPANY SNAPSHOT
TABLE 125.    SIMULAIDS: OPERATING SEGMENTS
TABLE 126.    SURGICAL SCIENCE: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01.    GLOBAL MEDICAL SIMULATION MARKET SEGMENTATION
FIGURE 02.    TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 03.    TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 04.    TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 05.    TOP INVESTMENT POCKETS
FIGURE 06.    MARKET SHARE ANALYSIS, 2016
FIGURE 07.    TASK TRAINER SIMULATION MARKET REVENUE, 2016-2023($MILLION)
FIGURE 08.    MANIKIN-BASED SIMULATION MARKET REVENUE, 2016-2023($MILLION)
FIGURE 09.    STANDARDIZED PATIENT SIMULATION MARKET REVENUE, 2016-2023($MILLION)
FIGURE 10.    LAPAROSCOPIC SURGICAL SIMULATORS MARKET REVENUE, 2016-2023($MILLION)
FIGURE 11.    ARTHROSCOPIC SURGICAL SIMULATORS MARKET REVENUE, 2016-2023($MILLION)
FIGURE 12.    CARDIOVASCULAR SURGICAL SIMULATORS MARKET REVENUE, 2016-2023($MILLION)
FIGURE 13.    GYNECOLOGY SURGICAL SIMULATORS MARKET REVENUE, 2016-2023($MILLION)
FIGURE 14.    OTHERS SURGICAL SIMULATORS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 15.    ULTRASOUND SIMULATION MARKET REVENUE, 2016-2023($MILLION)
FIGURE 16.    COMPARATIVE ANALYSIS OF MODEL-BASED SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17.    SIMULATION SOFTWARE MARKET REVENUE, 2016-2023($MILLION)
FIGURE 18.    PERFORMANCE RECORDING SOFTWARE MARKET REVENUE, 2016-2023($MILLION)
FIGURE 19.    VIRTUAL TUTORS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 20.    COMPARATIVE ANALYSIS OF WEB-BASED SIMULATION MARKET REVENUE, BY COUNTRY,  2016 & 2023 (%)
FIGURE 21.    VENDOR-BASED TRAINING MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 22.    CUSTOM CONSULTING SERVICES MARKET REVENUE, 2016-2023($MILLION)
FIGURE 23.    EDUCATIONAL SOCIETIES MARKET REVENUE, 2016-2023($MILLION)
FIGURE 24.    COMPARATIVE ANALYSIS OF SIMULATION TRAINING SERVICES MARKET REVENUE,  BY COUNTRY, 2016 & 2023 (%)
FIGURE 25.    COMPARATIVE ANALYSIS OF LOW-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 26.    COMPARATIVE ANALYSIS OF MEDIUM-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 27.    COMPARATIVE ANALYSIS OF HIGH-FIDELITY SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 28.    COMPARATIVE ANALYSIS OF ACADEMIC INSTITUTIONS & RESEARCH CENTERS MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 29.    COMPARATIVE ANALYSIS OF HOSPITALS & CLINICS MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 30.    COMPARATIVE ANALYSIS OF MILITARY ORGANIZATIONS MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 31.    3M: NET SALES, 2014–2016 ($MILLION)
FIGURE 32.    3D SYSTEMS: REVENUE SHARE BY PRODUCT & SERVICES, 2016 (%)
FIGURE 33.    3D SYSTEMS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34.    CAE: NET SALES, 2015–2017 ($MILLION)
FIGURE 35.    CAE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36.    CAE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37.    SURGICAL SCIENCE: NET SALES, 2014–2016 ($MILLION)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Have a question ?

Need to add more ?

Featured Readings

Get Fresh Content Delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Get Industry Data Alerts >